Care is led by experienced medical professionals, including Dr. Jeffrey Galvin and Ariel Curtis, FNP-C.
Hyaluronic acid injections, also called viscosupplementation or knee gel injections, can be considered for selected people with symptomatic knee osteoarthritis. The solution is placed inside the knee joint to supplement the joint fluid and support lubrication and cushioning. Responses vary, and several professional organizations do not recommend the treatment for routine use. It does not regrow cartilage or cure arthritis. Evaluation is important because knee pain can also come from injury, infection, instability, inflammatory disease, or another condition requiring a different treatment pathway.
Hyaluronic acid is a naturally occurring substance found in synovial fluid, the fluid inside a healthy knee joint. It contributes to the fluid’s slippery and shock-absorbing qualities, helping the joint surfaces move with less friction.
Osteoarthritis affects the entire knee joint. Changes can involve cartilage, bone, the joint lining, surrounding muscles, and synovial fluid. These changes can contribute to pain, stiffness, swelling, reduced walking tolerance, and difficulty using stairs.
A hyaluronic acid injection introduces a manufactured hyaluronate preparation directly into the knee joint. This procedure is called viscosupplementation. The treatment is intended to support symptom management rather than repair the structural cartilage loss caused by osteoarthritis.
The complete biological mechanism is not fully established. Hyaluronic acid injections are generally discussed through four practical treatment goals.
The injected solution adds a viscous substance to the synovial space. This is designed to supplement the lubricating and cushioning properties of the fluid inside an osteoarthritic knee.
Some patients experience improved comfort during walking, standing, stairs, or routine movement. The response is individual and does not occur in every patient.
Hyaluronic acid is not a corticosteroid. It is not selected primarily to suppress an acute inflammatory flare. A provider considers the symptom pattern, diagnosis, previous treatments, medical history, and treatment goals when comparing injection choices.
Improved pain or movement does not prove that cartilage has regenerated. Hyaluronic acid injections should not be presented as a cartilage-restoring, arthritis-reversing, or disease-curing procedure.
Hyaluronic acid injections are not a general treatment for every painful joint. This page focuses on selected knee osteoarthritis patients.
Viscosupplementation can be discussed when an evaluation supports knee osteoarthritis and symptoms continue to affect movement, activity, or daily function.
Common symptoms can include:
Detailed arthritis information is available on the Knee Arthritis Treatment Near Gastonia NC page.
Hyaluronic acid injections can be considered when osteoarthritis-related stiffness limits comfortable knee movement. The provider must first determine whether arthritis is the likely cause of the restriction.
Common symptoms can include:
A physically locked knee, major injury, deformity, or sudden inability to bear weight requires a different evaluation pathway.
Viscosupplementation is often discussed after reasonable non-surgical treatments have not provided enough symptom or functional improvement.
Previous care can include:
The provider reviews which treatments were attempted, how consistently they were used, and whether another care option should be considered first.
A hyaluronic acid injection is usually one part of a broader knee osteoarthritis treatment plan rather than a stand-alone solution.
The broader plan can include:
The goal is to support knee comfort, movement, and daily function without claiming cartilage restoration, permanent relief, or guaranteed surgery avoidance.
At Joint Health Solutions, the hyaluronic acid injection process is designed to be clear, comfortable, and provider-led. Your care plan is based on your knee symptoms, medical history, arthritis severity, and treatment goals.
Hyaluronic acid products differ in formulation, molecular characteristics, source, volume, and whether they are delivered as a single injection or a series. Product availability and insurance authorization can change.
| Product Example | General Treatment Format | Planning Considerations | Important Limitation |
|---|---|---|---|
| Orthovisc | Multi-injection series. | Scheduling, coverage, allergy history, and previous response. | Does not guarantee pain or functional improvement. |
| Hyalgan | Multi-injection series. | Requires completion of the prescribed product course. | Does not rebuild knee cartilage. |
| GenVisc | Multi-injection series. | Product-specific instructions and authorization apply. | Not appropriate for every cause of knee pain. |
| Monovisc | Single-injection formulation. | One-visit format can reduce scheduling burden. | A single injection does not guarantee a stronger response. |
| Durolane | Single-injection formulation. | Selection depends on evaluation and current availability. | Results and duration remain individual. |
The provider should select the product and treatment format only after confirming the knee diagnosis, reviewing relevant risks, and discussing evidence limitations.
For an appropriately selected knee osteoarthritis patient, viscosupplementation can:
These are potential symptom and function goals. They are not promises of structural healing or permanent relief.
Possible effects and complications include:
Contact the clinic promptly if pain or swelling becomes severe or continues to worsen. Fever with a hot, red, swollen knee, rapidly increasing swelling, inability to bear weight, new calf swelling, chest pain, or breathing difficulty requires prompt medical assessment.
An injection appointment should not be the first step after major trauma, obvious deformity, a physically locked knee, suspected infection, or sudden severe weakness.
The duration of improvement varies from person to person. Some patients notice gradual symptom relief, while others experience little or no meaningful change.
Results Can Depend On:
Repeat treatment should not be scheduled automatically. The provider should review the original response, duration of improvement, current symptoms, product guidance, and insurance requirements before recommending another injection.
Hyaluronic acid injections are not a permanent treatment and do not stop osteoarthritis from progressing.
You might need another evaluation pathway when symptoms are caused by major trauma, fracture, instability, infection, inflammatory arthritis, a mechanically locked knee, major tendon injury, blood clot concerns, or another condition not addressed by viscosupplementation.
Severe structural arthritis does not automatically mean that an injection is appropriate or inappropriate. The decision depends on symptoms, examination findings, previous treatment response, daily limitations, goals, and whether an orthopedic opinion is needed.
Hyaluronic acid and cortisone are different treatments. Neither is universally preferable.
| Consideration | Hyaluronic Acid Injection | Cortisone Injection |
|---|---|---|
| Primary Approach | Supplements the knee’s synovial fluid. | Reduces inflammation within or around the treated area. |
| Common Treatment Context | Selected symptomatic knee osteoarthritis patients. | Selected inflammatory or arthritis-related flare-ups. |
| Expected Response | Often gradual when improvement occurs. | Can produce a more rapid short-term response for some patients. |
| Evidence Considerations | Guidelines disagree, and routine use is not supported by every organization. | Can provide short-term symptom support for selected knee osteoarthritis patients. |
| Effect on Cartilage | Does not rebuild cartilage. | Does not rebuild cartilage. |
| Treatment Format | Single injection or product-specific series. | Individual injection plan based on clinical need. |
| Important Limitations | Cost, authorization, multiple visits, variable response, and no guaranteed duration. | Temporary effect, medication risks, and repeat-use considerations. |
| Selection Factors | Diagnosis, prior conservative care, expectations, product, and coverage. | Active inflammation, health history, medication risks, previous injections, and clinical findings. |
Neither option should be chosen solely because another person responded well to it. A provider should evaluate the knee and explain why one approach, another treatment, or no injection is appropriate.
The treatment decision begins with the knee diagnosis, symptom pattern, previous care, movement limitations, and patient goals rather than an automatic injection recommendation.
Provider-Guided Treatment Planning
Ariel Curtis, FNP-C, serves as Joint Injection Specialist, and Jeffrey Galvin, MD, serves as Medical Director. Treatment recommendations are individualized according to the clinical findings.
Ultrasound or fluoroscopy can be used when clinically appropriate to support controlled needle placement and confirmation of the intended knee target.
Different formulations have different labeling, schedules, costs, and insurance requirements. The team can review the planned product and available financial information before treatment.
Comprehensive Knee Care
Viscosupplementation can be coordinated with physical therapy, activity modification, low-impact exercise, nutrition and weight support, bracing, or orthopedic referral when those pathways are appropriate.
Transparent Access for Gastonia Patients
Joint Health Solutions serves patients from Gastonia and surrounding Gaston County communities at its physical clinic in Charlotte. Call 704-833-3566 to discuss scheduling and treatment evaluation.
No. These injections are considered primarily for selected patients with symptomatic knee osteoarthritis. Knee pain can also result from trauma, fracture, tendon injury, instability, infection, inflammatory arthritis, or mechanical problems. An evaluation helps determine whether osteoarthritis is the likely symptom source and whether viscosupplementation, another treatment, additional testing, or specialist referral is appropriate.
No. Hyaluronic acid injections should not be described as cartilage-regrowth treatment. Some patients experience improvements in pain, stiffness, movement, or activity tolerance, but symptom improvement does not demonstrate that lost cartilage has returned. The treatment supplements joint fluid and is intended for symptom management. It does not cure osteoarthritis or reverse structural joint degeneration.
The response is usually not immediate, and no exact onset can be promised. Some patients notice gradual changes after an injection or after completing the prescribed product series. Others experience little or no meaningful improvement. The provider will explain when to assess the response based on the formulation, symptoms, aftercare, and overall knee treatment plan.
The number depends on the specific product. Some formulations are delivered in one injection, while others require a scheduled series. The product should not be selected only according to the number of visits. The provider also considers the clinical findings, previous treatment, allergy history, current availability, product labeling, insurance authorization, cost, and patient preference.
No. Hyaluronic acid supplements the lubricating and cushioning properties of knee-joint fluid, while cortisone is an anti-inflammatory medication used primarily for short-term symptom support. Their response patterns, evidence, risks, and treatment courses differ. Neither treatment repairs lost cartilage or guarantees permanent relief. The provider should determine which option, if either, fits the diagnosis, symptom pattern, health history, medications, and previous response.
Most patients experience a brief needle sensation, pressure, or discomfort. Temporary soreness, fullness, or stiffness can occur afterward. The exact experience depends on knee sensitivity, swelling, anatomy, injection approach, and individual pain response. Tell the provider about previous injection reactions, anxiety, medication use, bleeding risks, and allergies before the procedure.
Coverage varies by insurance company, plan, diagnosis, medical-necessity criteria, product, prior authorization, and documentation of conservative treatment. Coverage should not be assumed before verification. Patients should review expected benefits and possible out-of-pocket costs before the procedure. The clinic can provide available information, but the insurer makes the final coverage decision.
Follow the individualized instructions provided after treatment. Patients are commonly advised to limit strenuous exercise, high-impact activity, heavy lifting, prolonged standing, or extended weight-bearing for a short period. Gentle routine movement might still be appropriate. Contact the clinic if discomfort becomes severe, swelling increases, or the knee becomes increasingly hot or red.
Neither injection is universally better. They use different approaches and can be considered for different clinical circumstances. Cortisone is generally discussed for short-term support when inflammation contributes to symptoms. Hyaluronic acid is considered for selected knee osteoarthritis patients and often has a more gradual response. Medical history, examination findings, previous treatment, risks, and evidence limitations should guide the decision.
Appointments are held at Joint Health Solutions, 9350 Benfield Rd, #109, Charlotte, NC 28269. The practice does not claim a physical office in Gastonia. Patients from Gastonia and Gaston County can call 704-833-3566 to schedule an evaluation and receive current information about appointments, product availability, insurance authorization, and directions.
Schedule an evaluation to determine whether knee osteoarthritis is contributing to your symptoms and whether viscosupplementation fits your diagnosis, previous care, medical history, and treatment goals.
